Epizyme (EPZM) PT Lowered to $26 at Wedbush, Following Earnings

May 6, 2021 3:20 PM EDT Send to a Friend

Wedbush analyst David Nierengarten lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Epizyme (EPZM) PT Lowered to $26 at Wedbush, Following Earnings

Member Login

Free News Feed